Teachers Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Teachers Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$108M	Buy	587,959 +111,219	+23%	+$20.5M	0.13%	147
2018 Q4	$79M	Sell	476,740 -157,163	-25%	-$27.2M	0.11%	182
2018 Q3	$122M	Sell	633,903 -192,982	-23%	-$34.4M	0.15%	140
2018 Q2	$141M	Sell	826,885 -20,433	-2%	-$3.17M	0.18%	112
2018 Q1	$138M	Buy	847,318 +39,593	+5%	+$6.47M	0.18%	116
2017 Q4	$121M	Buy	807,725 +50,865	+7%	+$7.53M	0.16%	133
2017 Q3	$115M	Buy	756,860 +72,677	+11%	+$10.9M	0.16%	139
2017 Q2	$88.2M	Buy	684,183 +173,810	+34%	+$20.9M	0.12%	195
2017 Q1	$55.8M	Buy	510,373 +166,998	+49%	+$14.7M	0.08%	306
2016 Q4	$25.3M	Buy	343,375 +12,707	+4%	+$1.03M	0.04%	523
2016 Q3	$28.8M	Sell	330,668 -105,352	-24%	-$9.96M	0.05%	448
2016 Q2	$37.5M	Buy	436,020 +114,689	+36%	+$9.91M	0.07%	359
2016 Q1	$25.5M	Sell	321,331 -6,036	-2%	-$546K	0.05%	463
2015 Q4	$41.2M	Buy	327,367 +5,571	+2%	+$673K	0.08%	328
2015 Q3	$33.5M	Sell	321,796 -1,344	-0.4%	-$173K	0.07%	379
2015 Q2	$39.9M	Sell	323,140 -80,821	-20%	-$10.2M	0.07%	352
2015 Q1	$47.7M	Sell	403,961 -24,039	-6%	-$2.88M	0.09%	299
2014 Q4	$50.8M	Buy	428,000 +15,719	+4%	+$1.77M	0.1%	273
2014 Q3	$46.3M	Buy	412,281 +33,062	+9%	+$3.15M	0.09%	278
2014 Q2	$35.9M	Buy	379,219 +11,941	+3%	+$837K	0.07%	359
2014 Q1	$26M	Sell	367,278 -156,837	-30%	-$12.4M	0.06%	461
2013 Q4	$38.9M	Buy	524,115 +70,326	+15%	+$4.9M	0.09%	295
2013 Q3	$34.4M	Buy	453,789 +17,900	+4%	+$1.42M	0.09%	296
2013 Q2	$34.8M	Buy	+435,889	New	+$32.1M	0.09%	279

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Teachers Advisors's VRTX Position: Q1 2019 in Review

Teachers Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 23% in Q1 2019, buying an estimated $20.5M and bringing the position to 587,959 shares worth $108M. The position accounts for 0.13% of the portfolio, ranked #147.

Teachers Advisors first reported a position in VRTX in Q2 2013 and has held it in 24 quarters since. The position peaked at $141M in Q2 2018. 736 funds tracked by Wall St. Rank hold VRTX as of Q1 2019.

Teachers Advisors held 587,959 shares of Vertex Pharmaceuticals worth $108M as of Q1 2019.
Teachers Advisors bought 111,219 Vertex Pharmaceuticals shares in Q1 2019, an estimated $20.5M.
Vertex Pharmaceuticals made up 0.13% of Teachers Advisors's portfolio in Q1 2019, its #147 holding.
Teachers Advisors first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
Teachers Advisors's Vertex Pharmaceuticals position peaked at $141M in Q2 2018.
736 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.